Upper digestive symptoms of chronic liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027739

Enrollment

Registered

2017-06-14

Start date

2017-06-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver disease

Interventions

changes of subjective symptoms after take vonopurazan on chronic liver disease patient changes of subjective symptoms after take vonopurazan on liver cirrhosis patient

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: over 20 years old patient who have chronic liver disease and agree the examination

Exclusion criteria

Exclusion criteria: patient who have hypersensitivity of vonopurazan and contraindicational drug

Design outcomes

Primary

Measure	Time frame
questionnaire survey on start of therapy,4weeks and 8weeks	—

Secondary

Measure	Time frame
endoscopic findings	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026